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Background: Maintaining glaucoma patients’ quality of life (QoL) has become one of the most important goals for
treatments. The purpose of this study is to develop a Chinese version of Glaucoma Quality of Life-15 item Questionnaire
(GQL-15-CHI), and examine its psychometric properties.
Methods: The Glaucoma Quality of Life-15 item Questionnaire (GQL-15) was translated and culturally adapted into
Chinese, and administered to glaucoma patients recruited from Shanghai Eye and ENT Hospital. Visual functions:
habitual-corrected visual acuity (HCVA), intraocular pressure (IOP), and mean defect (MD) of visual field) were
assessed through clinical examination by professionals. Sociodemographic and other clinical data were collected
via interviews and chart review. According to Nelson’s glaucoma staging system, patients were stratified as mild,
moderate, and severe visual field loss (VFL). The psychometric properties, including internal consistency, test-retest
reliability, item-scale correlations and factor analysis were conducted. The divergent validity was assessed through
bilateral comparisons of the GQL-15-CHI composite and subscale scores between patients of different VFLs after
controlling for potential confounders.
Results: A total of 508 glaucoma patients were recruited (male: 265, female: 243). The mean age was 55.41 years.
The Cronbach’s α coefficients ranged from 0.75 to 0.91 for the subscales. The test-retest reliability, as estimated by
the intraclass correlation coefficients, were above 0.70 for all subscales. Statistically significant differences were
showed in the GQL-15-CHI summary and subscale scores after controlling for sociodemographic and clinical
confounders (P < 0.05) among patients with different VFLs.
Conclusion: The GQL-15-CHI showed psychometric properties comparable to those of the original English version,
and thus could be used as a reliable and valid tool for assessment of QoL in Chinese glaucoma patients.Background
Glaucoma is the second leading cause of blindness world-
wide. It was estimated that about 8.4 million people were
blind due to glaucoma worldwide in the year of 2010, and
more than one-fourth of them lived in China [1,2]. Apart
from traditional measures, such as intraocular pressure
(IOP), perimetry, visual acuity, in recent years, assessment
of quality of life (QoL) is being increasingly recognized
as a critical measurement in monitoring and evaluating
the effectiveness of different treatments of glaucoma
[3-7]. “QoL” is a subjective perception of well-being and* Correspondence: qsh2304@163.com
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reproduction in any medium, provided the orwholeness. It is a broad concept incorporating the
patient’s perspective of his or her health. At the same
time, it reflects the difference between the patients’
expectations and their present status [8].
Glaucoma may impact patient’s QoL in several aspects:
the visual effects of glaucoma (decreased visual field and
ultimately visual acuity), the psychological burden caused
by diagnosis (fear of blindness [9], fear of affliction to
other members of the family, anxiety and depression [10]),
the potential side effects of treatment (medical and/or sur-
gical), and the financial burden (cost of visits and therapies
[11], loss of income because of absenteeism from work).
Even patients in the early stages of glaucoma experience
deficits in QoL associated with self-perceived visual dys-
function [3,4,12,13]. Therefore, maintaining a patient’std. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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treatments.
Compared to the generic patient-reported outcome mea-
sures (PROMs), such as the National Eye Institute Visual
Function Questionnaire 25 items [14,15], glaucoma-specific
questionnaires attached more importance to patients’
visual field loss (VFL) [4,16,17]. The Glaucoma Quality
of Life-15 (GQL-15) is one of them, and has been proved
to perform well among glaucoma patients [4].
The GQL-15 was extracted from the original 62 items
according to their relationship to visual field loss [13].
As this instrument is short and easy to use, it is accepted
worldwide. Various studies have consistently demon-
strated that GQL-15 score has a strong correlation with
objective visual measures [18-21]. However, the results
are also affected by different demographic or other fac-
tors, and the GQL-15 scores vary from region to region
[4,18,19,21]. At present, there are no validated Chinese
versions of QoL questionnaires specific to glaucoma
patients, thereby limiting the international comparison
of outcomes of treatment for Chinese glaucoma patients
[22]. Based on the interest in this field, we set out to
translate and validate the GQL-15 to use it in Chinese
glaucoma patients. Because transcultural adaptation of
a questionnaire requires that the questionnaire’s psycho-
metric properties are reestablished within the new cultural
and linguistic context [23,24], the aim of this study was to
develop the Chinese version of GQL-15 (GQL-15-CHI)




This study was approved by the Institutional Review
Board of Fudan University and adhered to the tenets of
the Declaration of Helsinki. Patients with glaucoma were
recruited from both office practice and wards in Shanghai
Eye and ENT Hospital from January to August 2012.
Informed consents were obtained from all patients.
Eligibility criteria were Chinese-speaking adult patients
(18 years or older) with a glaucoma diagnosis more than
6 months prior to enrollment [9,25]. Glaucoma was
diagnosed based on glaucomatous disc cupping and
reproducible visual field damage in one or both eyes.
Patients with primary open angle glaucoma (POAG),
normal tension glaucoma (NTG), primary angle-closure
glaucoma (PACG), and secondary glaucoma (SG) were
included in this study.
The exclusion criteria were: (1) major psychiatric prob-
lems; (2) the patient could not speak, read or understand
Mandarin-Chinese; (3) current use of any medication with
possible side effects of a psychiatric disorder or cognitive
impairment that might affect the psychological assessment,
e.g., systemic use of beta blockers [26,27]; (4) incisional eyesurgery within the previous three months or laser treat-
ment within the previous one month; (5) disability in
visual field testing due to causes other than glaucoma
(e.g., cognitive impairment such as dementia caused by
Alzheimer’s disease); (6) other severe vision-impaired
eye diseases (e.g., cataracts (Lens Opacities Classification
System III [28] grade 2 or more) and wet age-related
macular degeneration).
A trained interviewer explained the purpose of this
study to glaucoma patients, and they participated
voluntarily without any additional compensation. Of
the 552 patients who met the inclusion criteria, 36
declined to participate in our study due to time constraints.
Of the 516 subjects who agreed to participate, 8 patients
were excluded from the analysis because of incompletely
answered questionnaires, leaving a final sample size of 508.
All eligible patients were divided into three groups by
the severity of central visual field impairment according
to Nelson’s glaucoma staging system [4]: mild (unilateral
loss with less than half of the visual field lost), moderate
(unilateral loss with more than half of the visual field
lost, or bilateral loss with less than half of the visual field
lost in each eye), and severe (bilateral loss, more than
half of the visual field lost in both eyes).
Data collection
All interviews were performed by a trained interviewer
who was not involved in the ophthalmic examination.
Sociodemographic data including age, gender, living
situation, family history of glaucoma, duration of glau-
coma, education level, and personal monthly income,
were obtained through face-to-face interviews. Ques-
tionnaires were then completed before the examination
to ensure that the clinical data would not influence the
subjective responses. Twenty patients were retested
after two weeks to determine the test-retest reliability
of the questionnaire.
All eligible patients received comprehensive ophthalmic
examinations, including habitual-corrected visual acuity
(HCVA) using the Snellen visual acuity chart, intraocular
pressure (IOP) with a Goldmann applanation tonom-
eter, a complete ocular examination with slit-lamp bio-
microscopy, direct and indirect fudus ophthalmoscopy,
and a central 30° visual field evaluation using auto-
mated static perimetry (OCTOPUS 900, Haag-Streit
Eye Suite, Switzerland). Only “reliable” visual fields
were used, as defined by a reliability factor (RF) not
exceeding 15%. Clinical indices, such as mean defect
(MD) of visual field, number of IOP-lowering medica-
tions used, anti-glaucoma laser and surgeries in treat-
ment history, period on topical beta blocker eye drops
were also collected by chart review. The data were
labeled with serial numbers and analyzed in a way to
protect patient privacy.
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The GQL-15 [4] consists of 15 vision-related items,
which primarily cover four aspects: central and near
vision (two items), peripheral vision (six items), glare
and dark adaptation (six items), and outdoor mobility
(one item). Summary scores represented the sum of item-
level response scores, with higher scores indicating poorer
QoL. The item-level responses for each factor were coded
on a scale from 1 (no difficulty) to 5 (severe difficulty),
and 0 represented “abstinence from activity due to nonvi-
sual reasons”. For subscale scores, the item-level responses
were scored on a numerical interval scale ranging from 0
(no difficulty) to 100 (severe difficulty). Subscale scores
were calculated for each factor by averaging the sum of
scores generated for the item-level responses. Higher
subscale scores represented greater difficulty with vision-
related activities and poorer QoL.
Linguistic validation of GQL-15-CHI
The GQL-15-CHI was developed according to standard
methods that have been adopted internationally [29], in-
cluding forward translation, back translation, examination
of the translation quality by bilingual speakers, and a pilot
test among 20 patients. The wording of two items was
changed to better adapt them to the Chinese lifestyle and
culture. After reviewing the content of the translated
questionnaire by one glaucoma expert and one psycholo-
gist, a psychometric test was conducted.
The linguistic validation of GQL-15-CHI included six
steps:
1. The GQL-15-CHI was translated from English into
Chinese by two professional translators.
2. A panel (two translators and two glaucoma experts)
deliberated the Chinese translations to produce a
second draft of the GQL-15-CHI.
3. A third translator, who was not involved in the
forward translation and was blinded to the original
questionnaire, back translated the drafted GQL-15-
CHI into English.
4. The back-translated GQL-15-CHI was compared
with the original English version to identify any
discrepancies, which were then deliberated by the
panel.
5. Proper adaptation of some items was considered
necessary during the translation and validation of
the questionnaire in other populations [23,24,30,31].
Cognitive debriefing of the drafted GQL-15-CHI was
performed on 20 patients with glaucoma to test their
understanding and interpretation of the question-
naire, and two items were modified to make them
better understood. Patients were frequently confused
by some items, e.g. “judging distance of foot to step”
in the original version, and it was revised as “canyou figure out the distance between you and me or
how far is that object (e.g. the door) apart from
you?” Compared to the original form, this way was
more natural and vivid to Chinese patients, and all
participants could catch the exact meaning imme-
diately. Moreover, another puzzled item, “seeing
objects coming from the side”, and it was modified
to “unable to see the objects directly at the front
but being able to see objects coming from the side”
in the Chinese version to increase response
accuracy.
6. The final version of the GQL-15-CHI was established
after minor revisions based on the outcome of the
cognitive debriefing.
Statistical analyses
HCVA was converted to logarithm of the minimum angle
of resolution (logMAR). All statistical analyses were per-
formed using SAS software version 9.2 (SAS Institute,
Inc., Cary, NC).
Descriptive analyses
Descriptive statistics were used to determine the distri-
bution of sociodemographic and clinical characteristics,
and were reported as mean ± standard deviation (SD) or
proportion (%).
Reliability
Cronbach’s α coefficient was used as an index of in-
ternal consistency for each subscale. The optimal range
of Cronbach’s α was above 0.70. To quantify test-retest
reliability, intraclass correlation coefficients were used
[32]. Reliability coefficients above 0.70 were considered
satisfactory [33]. To further determine scale homogen-
eity, the item-cale correlation coefficient was calculated
and a coefficient greater than 0.40 was considered
acceptable [34]. The percentage of item response at the
ceiling (lowest subscore) and floor (highest subscore) of
the GQL-15-CHI were also calculated.
Validity
Five experts (three glaucoma specialists and two statisti-
cians) were invited to evaluate the face validity of the final
version of GQL-15-CHI. Exploratory factor analysis after
varimax rotation was used to further evaluate validity. To
test the discriminatory power of the questionnaire, first,
univariate comparisons of sociodemographic and clinical
data between patients of mild, moderate and severe VFL
were made using either analysis of variance (continuous
factors) or Chi-square test (categorical factors). Moreover,
post hoc pairwise comparisons between different categor-
ies of glaucoma severities were carried out using Turkey’s
honestly significant difference test. The significant variates
were considered as confounders in linear regression
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confounders, bilateral comparisons of the GQL-15-CHI
composite and subscale scores were made between
patients of mild, moderate and severe VFLs.
Results
Demographics
A total of 508 glaucoma patients were included in this
study. The mean age was 55.41 ± 15.23 years with a range
of 18–88 years, and 265 (52.17%) patients were male. TheTable 1 Sociodemographic and clinical characteristics of the C
Variable Total Mi
Number of participants 508 133
Age (years) 55.41 ± 15.23 50.30
Male gender 265(52.17) 65
Duration of glaucoma (years) 5.06 ± 6.31 3.53
Education
Below primary/primary (≤6 years) 68(13.39) 11
Secondary (7–13 years) 253(49.80) 60












Positive glaucoma family history 107(21.06) 30
Type of glaucoma
PACG 178(35.04) 35
POAG and NTG 264(51.97) 76
Secondary glaucoma 66(12.99) 22
LogMAR HCVA in better eye 0.20 ± 0.37 0.06
LogMAR HCVA in worse eye 0.80 ± 0.99 0.24
MD in better eye 7.02 ± 6.62 1.20
MD in worse eye 14.53 ± 8.79 4.91
Period on using topical beta blocker (years) 1.04 ± 2.31 0.55
Number of antiglaucoma medication used 1.57 ± 1.10 1.33
Number of glaucoma surgery in treatment history 0.84 ± 1.07 0.56
Number of laser intervention in glaucoma treatment 0.36 ± 0.78 0.39
Higher IOP of both eyes 20.32 ± 9.49 18.0
Data are presented as mean ± SD or n(%); P1: mild vs. moderate; P2: mild vs. severe;
glaucoma; POAG: primary open-angle glaucoma; NTG: normal tension glaucoma; Lo
visual acuity; MD: mean defect of visual field; IOP: intraocular pressure.mean duration of glaucoma was 5.06 ± 6.31 years, ranging
from 0.5 to 49.0 years. Age, education level, duration of
glaucoma, HCVA (both in the better eye and the worse
eye), MD (both in the better eye and the worse eye), and
higher IOP of both eyes were all found to be significantly
different among patients with different VFLs. No signifi-
cant differences were found with respect to gender, living
situation, or family history of glaucoma among the three
groups. The overall sociodemographic and clinical charac-
teristics of the patients are summarized in Table 1.hinese patients with glaucoma
ld VFL Moderate VFL Severe VFL P P1 P2 P3
(26.18) 306(60.24) 69(13.58)
± 16.07 57.22 ± 14.35 57.22 ± 15.32 <.01 <.01 0.01 1.00
(48.87) 163(53.27) 37(53.62) 0.68 0.40 0.52 0.96
± 4.32 5.14 ± 5.62 7.63 ± 10.40 <.01 0.04 <.01 0.01




0.76 0.57 0.48 0.74
(93.98) 283(92.48) 63(91.30)
(6.02) 23(7.52) 6(8.70)








(22.56) 59(19.28) 18(26.09) 0.40 0.43 0.58 0.21




± 0.13 0.17 ± 0.25 0.59 ± 0.73 <.01 <.01 <.01 <.01
± 0.29 0.86 ± 1.00 1.60 ± 1.15 <.01 <.01 <.01 <.01
± 1.11 6.49 ± 3.53 20.57 ± 3.86 <.01 <.01 <.01 <.01
± 3.59 16.51 ± 7.36 24.32 ± 3.45 <.01 <.01 <.01 <.01
± 1.37 1.00 ± 1.91 2.17 ± 4.25 <.01 0.17 <.01 <.01
± 0.93 1.54 ± 1.08 2.19 ± 1.25 <.01 0.17 <.01 <.01
± 1.03 0.90 ± 1.02 1.12 ± 1.23 <.01 <.01 <.01 0.37
± 0.81 0.36 ± 0.74 0.30 ± 0.90 0.76 1.00 1.00 1.00
8 ± 5.51 20.54 ± 9.86 23.68 ± 12.41 <.01 0.04 <.01 0.04
P3: moderate vs. severe. VFL: visual field loss; PACG: primary angle closure
gMAR: logarithm of the minimum angle of resolution; HCVA: habitual corrected
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The Cronbach’s α coefficient (internal consistency index)
was 0.96 for the overall analyses and ranged from 0.75
to 0.91 for the subscales (Table 2). The test-retest reli-
ability, as estimated by the intraclass correlation coeffi-
cients, were greater than 0.70 for all subscales (Table 2).
These two tests were not applied to the subscale of out-
door mobility, which was composed of only one item.
The item-scale correlation coefficient was calculated to
determine scale homogeneity and showed that the coef-
ficients were all above 0.40: item-total scale correlation
coefficients ranged from 0.56 to 0.81 and item-subscale
correlation coefficients ranged from 0.54 to 1.00 (Table 2).
Floor effect was not found in any of the subscales. How-
ever, the percentage of subjects scoring at the ceiling was
over 20% in three subscales (Central and near vision,
Peripheral vision and Outdoor mobility).
Validity
Five experts evaluated the face validity of the question-
naire, and the results showed a face validity index of
0.98. The mean summary score for the GQL-15-CHI
was 28.79 ± 12.74 and the mean subscale scores were as
follows: central and near vision (26.18 ± 26.56), periph-
eral vision (18.03 ± 21.37), glare and dark adaptation
(28.19 ± 22.86), and outdoor mobility (15.06 ± 24.57).
Of these four factors, the scores for glare and darkTable 2 Reliability analysis of Chinese version of Glaucoma Q




Central and near vision
Recognizing faces 0.64 0.58
Reading newspapers 0.69 0.58
Peripheral vision
Seeing objects coming from the side 0.61 0.61
Walking on uneven ground 0.78 0.74
Tripping over objects 0.69 0.72
Judging distance of foot to step 0.63 0.65
Walking on steps/stairs 0.76 0.74
Bumping into objects 0.69 0.73
Glare and dark adaptation
Walking after dark 0.81 0.80
Seeing at night 0.78 0.77
Adjusting to dim light 0.69 0.70
Adjusting to bright light (glare) 0.56 0.54
Going from light to dark room or vice versa 0.72 0.73
Finding dropped objects 0.77 0.70
Outdoor mobility
Crossing the road 0.77 1.00
NA: not available for only one-item subscale.adaptation were consistently higher than the others,
while the scores for outdoor mobility were the lowest.
In order to test the divergent validity, patients were
classified as mild, moderate, and severe VFL according
to Nelson’s glaucoma staging system. After controlling
for age and gender, it showed a significant difference be-
tween the three groups in GQL-15-CHI composite and
subscores (P < 0.01, not shown in Table 3). This trend
was not weakened after adjustment for sociodemo-
graphic factors, which included educational level, per-
sonal monthly income, economic burden (P < 0.01, not
shown in Table 3). After further adjustment for clinical
indices, which included duration of glaucoma, logMAR
HCVA of the better eye and the worse eye, period on
topical beta blocker, number of glaucoma surgeries in
treatment history, number of antiglaucoma medications
used, higher IOP of both eyes, patients with increasing
severity of VFL consistently had higher mean ranks of
GQL-15-CHI summary and subscale scores (Table 3,
P < 0.05).
Exploratory factor analysis after varimax rotation
was used to further evaluate validity and the results are
shown in Table 4. Items were included only if they
loaded on a factor and had a loading greater than 0.40.
Factor analysis indicated that GQL-15-CHI was com-
prised of four factors explaining 68.22% of the cumula-
tive variation.uality of Life-15 item Questionnaire (GQL-15-CHI)
scale
tion
Cronbach α Intraclass correlation
coefficient
Ceilingn (%) Floorn (%)
0.75 0.73 (0.65-0.79). 158 (31.10) 11 (2.17)
0.91 0.91 (0.90-0.92) 143 (28.15) 3 (0.59)
0.90 0.90 (0.88-0.91) 54 (10.63) 1 (0.20)
NA NA 249 (49.01) 15 (2.95)
Table 3 Divergent validity of Chinese version Glaucoma Quality of Life-15 (GQL-15-CHI) of patients with different visual
field loss*
Variables Mild VFL Moderate VFL Severe VFL
β(SE) P β(SE) P
CHI-GQL-15 summary score 20.76 ± 6.12 28.73 ± 10.81 44.55 ± 15.33
Reference 4.63(1.04) <0.01 15.43(1.62) <0.01
Reference 10.80(1.36) <0.01
Central and near vision 11.18 ± 14.78 26.84 ± 24.82 52.17 ± 30.77
Reference 0.72(0.18) <0.01 1.93(0.29) <0.01
Reference 1.21(0.24) <0.01
Periphery vision 5.55 ± 9.13 17.42 ± 17.77 44.87 ± 28.12
Reference 1.65(0.44) <0.01 6.48(0.68) <0.01
Reference 4.83(0.57) <0.01
Glare and dark adaptation 14.16 ± 13.73 28.59 ± 20.62 53.44 ± 24.44
Reference 2.09(0.48) <0.01 5.93(0.74) <0.01
Reference 3.84(0.62) <0.01
Outdoor mobility 3.38 ± 9.62 13.48 ± 20.75 44.57 ± 35.06
Reference 0.17(0.08) <0.01 1.09(0.13) <0.01
Reference 0.92(0.11) 0.04
The CHI-GQL-15 summary and subscale scores were presented as mean ± standard deviation; SE: standard error; VFL: visual field loss; *adjusted for age, gender,
education, personal monthly income, economic burden, duration of glaucoma, logarithm of the minimum angle of resolution (logMAR) habitual-corrected visual
acuity (HCVA) of the better eye and the worse eye, period on topical beta blocker, number of glaucoma surgeries in treatment history, number of antiglaucoma
medication used, higher intraocular pressure of both eyes.
Table 4 Factor loading of Chinese version Glaucoma Quality of Life-15 (GQL-15-CHI) after varimax rotation
CHI-GQL-15 items Factor 1 Factor 2 Factor 3 Factor 4
11. Walking on steps/stairs 0.91 0.11 -0.01 0.13
10. Crossing the road 0.90 0.10 -0.01 0.18
4. Walking on uneven ground 0.71 0.06 0.33 0.09
8. Tripping over objects 0.37 0.77 0.16 -0.01
9. Seeing objects coming from the side -0.01 0.69 -0.22 0.16
12. Bumping into objects 0.53 0.65 -0.08 0.03
1. Reading newspapers 0.06 -0.74 0.01 0.18
6. Adjusting to dim light -0.02 -0.01 0.78 -0.06
7. Going from light to dark room or vice versa -0.02 0.07 0.75 0.01
3. Seeing at night 0.21 -0.17 0.69 0.40
2. Walking after dark 0.43 -0.07 0.69 0.32
13. Judging distance of foot to step 0.42 0.23 -0.46 0.31
15. Recognizing faces -0.02 -0.30 0.05 0.85
14. Finding dropped objects 0.28 0.17 0.06 0.69
5. Adjusting to bright light (glare) -0.25 -0.53 -0.13 -0.60
Eigenvalue 4.44 2.82 1.73 1.24
Variance explained (%) 29.61 18.81 11.50 8.30
Bold numbers represents the factor loading of the items.
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In this study, we developed a Chinese version of the
GQL-15 and evaluated its psychometric properties in
Chinese glaucoma patients. Overall, we demonstrated
that the GQL-15-CHI was reliable, valid, and able to
discriminate the severity of glaucoma.
With respect to the reliability, the overall Cronbach’s α
coefficient was 0.96 in this study, which was similar to
that of the original version (0.95) [4]. The Cronbach’s α
coefficients for the subscales were all greater than 0.70,
indicating satisfactory internal consistency of the ques-
tionnaire in the studied population. Considering that
intraclass correlation coefficients greater than 0.70 are
generally accepted as satisfactory, our results suggested
that the GQL-15-CHI demonstrated good test-retest re-
liability. High item-scale and item-subscale correlations
further confirmed the excellent homogeneity of the ques-
tionnaire. A ceiling effect was noted for the subscale of
central and near vision, peripheral vision, and outdoor
mobility. Good performance in the three subscales may in-
dicate patients’ adaptation in handling the daily activities
involving these aspects. Furthermore, GQL-15-CHI is
probably to be sensitive to any worsening of QoL through-
out all four domains as no floor effect was observed.
Because the GQL-15 was designed for subjective assess-
ment of visual functions in glaucoma patients to guide the
treatment, it was important for the questionnaire to have
strong discriminatory power. Our results showed that the
GQL-15-CHI had a good capacity to discriminate the se-
verity of glaucoma. Greater difficulty with vision-related
activities and poorer QoL were found to be highly corre-
lated with increasing disease severity even after adjust-
ment for all sociodemographic and clinical confounders.
This finding indicated that the subjective visual function
assessment could function as a complement to objective
visual measures, and was informative and predictive in the
follow-ups of glaucoma patients. This suggests value for
the ophthalmologist in establishment of a baseline QoL
upon diagnosis of glaucoma and periodically thereafter.
Nelson et al. [4] observed a marked difference in GQL-
15 summary scores only between patients with mild and
severe glaucoma. Onakoya et al. [19] detected statistically
significant differences between patients with moderate
and severe glaucoma and mild and severe glaucoma.
However, in our study the differences among patients in
all stages of glaucoma were statistically significant, con-
sistent with results reported by Goldberg et al. [18]. How-
ever, after categorization, the mean summary scores for
moderate and severe glaucoma in our study (28.73 and
44.55) were significantly higher than those reported by
Nelson et al. [4] (22.5 and 24.9) and Onakoya et al. [19]
(20.58 and 32.65). The trend among the mean summary
scores for different stages of glaucoma in our study (20.76,
28.73, and 44.55) was similar to that previously found byGoldberg et al. [18] (21.7, 29.6, and 40.0). Potential
explanations for this discrepancy may lie in cultural
and/or social variances, varied sample sizes (China: 508;
Nigeria: 132; Australia: 121; England: 47), different
methods for categorization of patients, and dissimilar
patient selection criteria. With respect to patient selec-
tion, different age distributions (China: 18–88 years;
Nigeria: ≥40 years; Australia: ≥44 years; England: 53–
81 years) and types of glaucoma (China: POAG,
NTG, PACG and SG; Nigeria: POAG; Australia: POAG;
England: POAG, NTG, PACG and SG) were partially
responsible for the discrepancies. Moreover, Nelson
et al. [4] excluded patients with progressive visual fields
and visual impairment to reduce the effect of visual acu-
ity on the study; whereas our study, Goldberg et al. [18],
and Onakoya et al. [19] did not. Although Nelson’s
study presented with a good homogeneity, it probably
limited the diversity of disease severities.
The results of the factor analysis in our study were
not fully conformed to the item distribution of the four
dimensions in the original version. The explanations
underlying this difference may relate to the following
aspects: First and foremost, compared to the Nelson’s
patient sample, we had a much larger and heteroge-
neous patient population. In a certain sense, the finding
in our study demonstrated that the original version may
not generalize to the patients of more severe glaucomat-
ous impairment. Second, the cultural differences may
still exist and result in a deviation in perceiving the
items of the questionnaire, although we modified some
items to make it more adaptable to Chinese patients.
Third, social variance could cause a difference in the re-
sponse to some specific items, e.g. for the item “crossing
the road”, the traffic is crowded in China for the largest
population in the world, and this is more pronounced in
the metropolitans, such as Shanghai. In addition, item
13 did not fit a specific dimension, while items 2, 3 and
12 were far from being perfect. Consequently, the Chinese
patients were more likely to express difficulty in response
to this item. Rasch analysis, may be used as a possible
method to reengineer the GQL-15-CHI to be a better-
structured questionnaire in future research [35].
Although the psychometric characteristics of the GQL-
15-CHI were comparable with those of the original ver-
sion, the following limitations should be considered
when interpreting the results of this study. First, reli-
ance on self-reported visual symptoms may be influ-
enced by recall bias and personality factors. Second, all
patients in this study were recruited from a single ter-
tiary institution and belonged to the Chinese Han ethni-
city. Although this specialized hospital received patients
from all parts of China and Han ethnicity takes up more
than 91% of total Chinese population, there may still
exists selection bias. In addition, we made six months as
Zhou et al. Health and Quality of Life Outcomes 2013, 11:188 Page 8 of 9
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which can also cause a deviation in selecting the pa-
tients. Third, we did not include controls in this study,
thereby limiting the conclusions that we can draw from
the study regarding whether or not it can discriminate
between glaucoma and other visual-impaired disease.
Fourth, we did not cover all ocular examinations ori-
ginally reflected by the original GQL-15 design, such
as contrast sensitivity, critical flicker frequency, dark
adaptation, glare disability, and stereoacuity. Lastly,
this study did not carry out over time for longitudinal
observation, and confirmatory factor analysis was not
conducted in another sample to validate our findings.
Therefore, a larger series with long-term follow-up in-
cluding control groups and other parameters is needed
to further validate the GQL-15-CHI in Chinese popu-
lations. Despite these limitations, this study included a
large sample size. Moreover, the comprehensive ophthalmic
examinations were performed by one expert and therefore
avoiding the inter-observer errors.
Conclusions
We successfully translated and adapted the GQL-15
into Chinese and demonstrated that its psychometric
characteristics were comparable with the original ques-
tionnaire. In particular, the GQL-15-CHI had strong
clinical discriminatory power with respect to severity
of glaucoma, making it a reliable and valid tool to help
patients and clinicians better manage the disease. Given
its simplicity, brevity, and significant relationship with
VFL, the GQL-15 will facilitate the comparison of multi-
center and multilingual research.
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